Last reviewed · How we verify
Evaluation of Type 2 Diabetes Treatment
The aim of this study is to analyze the efficacy of Diabeton 60 MR as intensive sugar-lowering therapy into routine clinical practice, in patients for whom the treating physician has already decided to prescribe this medication. This concerns untreated newly diagnosed patients uncontrolled by diet, and patients uncontrolled by metformin.
Details
| Lead sponsor | Servier Affaires Médicales |
|---|---|
| Status | COMPLETED |
| Enrolment | 105 |
| Start date | Thu Sep 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sat Jun 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Type2 Diabetes
Interventions
- Diabeton 60 MR
Countries
Azerbaijan